Presentation TCT 2016 Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies Presenter: Ajay J. Kirtane, Bryan Williams, Wilko Spiering October 30, 2016
Presentation TCT 2016 Carotid Sinus Stimulation: Critical Analysis of the 1st and 2nd Generation CVRx Device Results Presenter: Ajay J. Kirtane, Bryan Williams, Atul Pathak October 30, 2016
Presentation TCT 2016 Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates? Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Martin B. Leon October 30, 2016
Presentation TCT 2016 Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness? Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Justin E. Davies October 30, 2016
Presentation TCT 2016 Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari October 30, 2016
Presentation TCT 2016 TCT 500: Global Right Ventricular Longitudinal Peak Systolic Strain Predicts clinical Outcome After Pulmonary Artery Denervation for Patients with Pulmonary Arterial Hypertension Presenter: Irene M. Lang, Ehtisham Mahmud October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Kona WAVE IV Trial Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Roland E Schmieder October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Laura Mauri October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, William B. White October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari October 30, 2016
Presentation TCT 2016 TCT 769: Ultrasound-Assisted Catheter-Directed Thrombolysis in the Treatment of High Risk Pulmonary Embolism: A Meta-Analysis Presenter: Irene M. Lang, Ehtisham Mahmud October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Boston Scientific REINFORCE Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Ajay J. Kirtane October 30, 2016
Presentation TCT 2016 Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Bryan Williams October 30, 2016
Presentation TCT 2016 TCT 825: Simplicity Denervation System for Pulmonary Artery Denervation in Patients with Chronic Thrombembolic Pulmonary Hypertension (first-in-man study) Presenter: Irene M. Lang, Ehtisham Mahmud October 30, 2016
Presentation TCT 2016 Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Horst Sievert October 30, 2016
Presentation TCT 2016 Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Felix Mahfoud October 30, 2016
Presentation TCT 2016 Hypertension Treatment Targets Beyond the Kidneys Presenter: Felix Mahfoud, Michael A. Weber, Atul Pathak October 30, 2016
Presentation TCT 2016 The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology) Presenter: Felix Mahfoud, Michael A. Weber, Michael Joner October 30, 2016
Presentation TCT 2016 Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management? Presenter: Felix Mahfoud, Michael A. Weber, Ehtisham Mahmud October 30, 2016
Presentation TCT 2016 Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others) Presenter: Felix Mahfoud, Michael A. Weber October 30, 2016